½ÃÀ庸°í¼­
»óǰÄÚµå
1427004

¼¼°èÀÇ Àν¶¸° Ææ ½ÃÀå

Global Insulin Pen Market

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BCC Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 78 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è Àν¶¸° Ææ(Insulin Pen) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä, ½ÃÀå ¿µÇâ¿äÀÎ ¹× ½ÃÀå ±âȸ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, °¢Á¾ ºÎ¹®º°/Áö¿ªº° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ¿ä¾à ¹× ÇÏÀ̶óÀÌÆ®

  • ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ä¾à
  • º¸°í¼­ ÇÏÀ̶óÀÌÆ®

Á¦3Àå ½ÃÀå °³¿ä¡¤Á¤ÀÇ

  • °³¿ä
  • ´ç´¢º´
  • 1Çü ´ç´¢º´
  • 2Çü ´ç´¢º´
  • Àν¶¸°ÀÇ ¿ªÇÒ
  • ´ç´¢º´ Ä¡·á
  • ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦

Á¦4Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ½ÃÀå °³¿ä ¹× ³íÀÇ
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ±âŸ Áö¿ª

Á¦5Àå ½ÃÀå ³»¿ª : ¹ßÇö ½Ã°£º°

  • ½ÃÀå °³¿ä ¹× ³íÀÇ
  • ÁöÈ¿¼º Àν¶¸°
  • ¼ÓÈ¿¼º Àν¶¸°
  • Áß°£Çü Àν¶¸°
  • ´Ü½Ã°£ ÀÛ¿ëÇü Àν¶¸°
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • Áö¼ÓÇü Àν¶¸° Ææ
  • Áß°£Çü Àν¶¸° Ææ
  • ´Ü½Ã°£ ÀÛ¿ëÇü Àν¶¸° Ææ
  • ¼ÓÈ¿¼º Àν¶¸° Ææ

Á¦6Àå ½ÃÀå ³»¿ª : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • º´¿ø
  • ¾à±¹
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø
  • ¼¼°èÀÇ Àν¶¸° Ææ ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå
  • ºÏ¹ÌÀÇ ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå
  • À¯·´ÀÇ ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå
  • ±âŸ Áö¿ªÀÇ ÃÖÁ¾»ç¿ëÀÚº° ½ÃÀå

Á¦7Àå ESG Àü°³

  • ȯ°æ
  • »ç±³
  • °Å¹ö³Í½º
  • »ç·Ê ¿¬±¸
  • Novo Nordisk A/S
  • BCCÀÇ °á·Ð

Á¦8Àå °æÀï ±¸µµ

  • °³¿ä¿Í ¾÷°è ½Ã³ª¸®¿À
  • ±â¾÷ Á¡À¯À²
  • ÃÖ±ÙÀÇ ÁÖ¿ä Àü°³

Á¦9Àå ±â¾÷ °³¿ä

  • ASTRAZENECA
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JOHNSON & JOHNSON SERVICES INC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • VIATRIS INC.

Á¦10Àå ºÎ·Ï : µÎÀÚ¾î

LSH 24.03.04

This report examines the global insulin pen market. It includes a detailed analysis and prediction of commercially significant products such as reusable and disposable insulin pens. This report investigates global insulin pen market patterns and features between 2022–2028, offering valuable insights and forecasts.

Report Scope:

This report thoroughly examines the worldwide market size of global insulin pen delivery technology, enhancing its appeal to stakeholders and readers alike. Current and historical market revenues are estimated based on the type, duration, end user and region.

Report Includes:

  • An overview of the global market for insulin pen
  • Analyses of global market trends, with data from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Evaluation of the current market size and revenue growth prospects specific to insulin pen, accompanied by a comprehensive market share analysis categorized by type, onset time, end user, and geographical region
  • A look at the innovations, technological advancements, and the launch of novel products from market players
  • Detailed analysis of the regulatory framework and policies and product pipeline of the industry, and discussion on ESG challenges and ESG practices in the insulin pen market
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology
  • Information Sources
  • Secondary Research
  • Geographic Breakdown
  • Segmentation Breakdown

Chapter 2 Summary and Highlights

  • Market Outlook
  • Market Summary
  • Report Highlights

Chapter 3 Market Overview and Definitions

  • Overview
  • Diabetes
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Role of Insulin
  • Diabetes Treatment
  • Market Dynamics
  • Market Drivers
  • Market Restrains
  • Market Opportunities
  • Market Challenges

Chapter 4 Market Breakdown by Region

  • Market Overview and Discussion
  • Market Size and Forecast
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 5 Market Breakdown by Onset Time

  • Market Overview and Discussion
  • Long-Acting Insulin
  • Rapid-Acting Insulin
  • Intermediate-Acting Insulin
  • Short-Acting Insulin
  • Market Size and Forecast
  • Long-Acting Insulin Pens
  • Intermediate-Acting Insulin Pens
  • Short-Acting Insulin Pens
  • Rapid-Acting Insulin Pens

Chapter 6 Market Breakdown by End User

  • Market Overview
  • Hospitals
  • Pharmacies
  • Market Size and Forecast
  • Global Insulin Pen End-Users Market
  • North American End-User Market
  • European End-User Market
  • Asia-Pacific End-User Market
  • Rest of the World End-User Market

Chapter 7 ESG Development

  • Introduction
  • Environmental
  • Social
  • Governance
  • Case Study
  • Novo Nordisk A/S
  • Concluding Remarks from BCC

Chapter 8 Competitive Landscape

  • Overview and Industry Scenario
  • Company Shares
  • Recent Key Developments

Chapter 9 Company Profiles

  • ASTRAZENECA
  • BIOCON
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • ELI LILLY AND CO.
  • JOHNSON & JOHNSON SERVICES INC.
  • MERCK & CO. INC.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • SANOFI
  • VIATRIS INC.

Chapter 10 Appendix: Acronyms

  • List of Acronyms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦